NIH-funded research R37 grant

Resilience-based program to boost quality of life after lymphoma treatment

Official title: Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

Funded at Massachusetts General Hospital · NIH-11415044 · Data updated 2026-11-12

A virtual group program called SMART3RP-lymphoma will be offered to lymphoma survivors 0–2 years after finishing treatment to help improve their long-term quality of life.

More Resilience research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 12, 2025
Project endAugust 31, 2030
Funding year2026
Award (this year)$793,875
NIH project number5R37CA303094-02
Project IDNIH-11415044 on NIH RePORTER

Who could benefit from this research

Could help

Adults who completed curative-intent lymphoma treatment within the past 0–24 months and are experiencing adjustment challenges.

Less likely to help

Patients who are not in the posttreatment window or who do not experience psychosocial distress may not benefit.

What this research studies

This project tests a virtual resilience group designed for people who have completed lymphoma treatment. It focuses on improving mood, coping skills, and daily functioning during early survivorship. The program uses evidence-based group activities delivered online to support physical and emotional well-being after therapy. Participants will share experiences and strategies in a supportive, structured setting to adapt to life after treatment.

Why it matters

Potential benefit: If successful, the program could help lymphoma survivors feel better day-to-day and manage long-term challenges after treatment.

How similar studies have gone: Earlier resilience programs have shown benefits for cancer survivors, supporting the potential usefulness of this approach.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Perez-Lougee, Giselle Katiria — Massachusetts General Hospital
  • Study coordinator: Perez-Lougee, Giselle Katiria

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.